Diversion Control Division, US Department of Justice, Drug Enforcement Administration

RESOURCES > Federal Register Notices > Manufacturers Notice of Application - 2008 > American Radiolabeled Chemical, Inc.

Manufacturers Notice of Application - 2008

FR Doc E8-17971[Federal Register: August 6, 2008 (Volume 73, Number 152)] [Notices] [Page 45785] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr06au08-95]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Application

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on June 11, 2008, American Radiolabeled Chemical, Inc., 101 Arc Drive, St. Louis, Missouri 63146, made application by renewal to the Drug Enforcement Administration (DEA) as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II:

Drug Schedule
Gamma hydroxybutyric acid (2010)  I
Ibogaine (7260)  I
Lysergic acid diethylamide (7315)  I
Tetrahydrocannabinols (7370)  I
Dimethyltryptamine (7435)  I
1-[1-(2-Thienyl)cyclohexyl]piper-idine (7470)  I
Dihydromorphine (9145)  I
Normorphine (9313)  I
Amphetamine (1100)  II
Methamphetamine (1105)  II
Amobarbital (2125)  II
Phencyclidine (7471)  II
Phenylacetone (8501)  II
Cocaine (9041)  II
Codeine (9050)  II
Dihydrocodeine (9120)  II
Oxycodone (9143)  II
Hydromorphone (9150)  II
Ecgonine (9180)  II
Hydrocodone (9193)  II
Meperidine (9230)  II
Metazocine (9240)  II
Dextropropoxyphene, bulk (non-dosage forms) (9273)  II
Morphine (9300)  II
Oripavine (9330)  II
Thebaine (9333)  II
Oxymorphone (9652)  II
Phenazocine (9715)  II
Fentanyl (9801)  II

The company plans to manufacture small quantities of the listed controlled substances as radiolabeled compounds for biochemical research.

Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).

Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than October 6, 2008.

Dated: July 29, 2008.

Joseph T. Rannazzisi, 
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. E8-17971 Filed 8-5-08; 8:45 am]

BILLING CODE 4410-09-P

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Publishing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility